Table 1.
Mean results at baseline and at 3 months
| Study eyes (n = 40)
|
Fellow eyes (n = 40)
|
|||
|---|---|---|---|---|
| Baseline | 3 months | Baseline | 3 months | |
| BCVA (logMAR) | 0.395 | 0.222* | 0.047 | 0.057 |
| Ta (mmHg) | 15.67 | 15.58 | 15.68 | 15.97 |
| Tp (mmHg) | 16.50 | 16.84 | 16.77 | 17.09 |
| MD | −2.75 | −1.61* | −1.50 | −1.06 |
| PSD | 2.35 | 2.60 | 2.50 | 2.08 |
| CCT (μm) | 557 | 559 | 561 | 561 |
| C/D ratio | 0.45 | 0.46 | 0.46 | 0.44 |
| RNFL (μm) | 94.10 | 91.05 | 92.59 | 93.13 |
| CSF (μm) | 387.4 | 307.4** | 257.1 | 259.4 |
Notes:
*
P = 0.02 between baseline and 3 months;
**
P < 0.001 between baseline and 3 months.
Abbreviations: BCVA, best corrected visual acuity; logMAR, logarithm of the minimal angle of resolution; Ta, intraocular pressure measured by Goldmann applanation; Tp, intraocular pressure measured by Tono-Pen; MD, mean deviation; PSD, pattern standard deviation; CCT, central corneal thickness; C/D ratio, cup-to-disc ratio; RNFL, retinal nerve fiber layer thickness; CSF, central subfield thickness.